Singapore's Q4 Economy Grows 5.7%, Boosted by Pharmaceuticals and Electronics Manufacturing

Deep News
01/02

Singapore's pharmaceutical and electronics manufacturing sectors provided momentum for economic growth in the fourth quarter, with the full-year growth rate reaching its fastest pace since the post-pandemic recovery, weathering the impact of tariffs from the Trump administration in the United States.

Preliminary data released by Singapore's Ministry of Trade and Industry showed that fourth-quarter gross domestic product grew 5.7% year-on-year, falling short of the median estimate of 6.3% from a media survey but exceeding the 4.3% growth rate recorded in the third quarter.

By sector, manufacturing grew 15% year-on-year, benefiting from strong performance in the pharmaceutical industry and rising demand for semiconductors, servers, and related products associated with artificial intelligence.

The impact of Trump's tariff measures on trade-dependent Singapore proved weaker than anticipated, with exports demonstrating resilience, while a recovery in the construction sector also bolstered domestic economic activity.

Singapore's Prime Minister Lawrence Wong stated in a New Year's address on Wednesday, "We must be realistic: sustaining this pace of growth will be challenging. We will encounter more obstacles to growth, and inflationary pressures could also intensify."

Singapore's Ministry of Trade and Industry predicted in November that economic growth could slow to a range of 1% to 3% in 2026.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10